Latest in Research News

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

  • At 36, I’m Fighting to Save my Eyesight

    May 27, 2020

    At the age of 36, I’m fighting to save my eyesight. For me, vision problems are a complication related to living with...

  • JDRF Partner’s Paper Shows Huge Upsides to Telemedicine

    May 26, 2020

    Virtual Visits Can Transform Care and Improve Outcomes for People with T1D

  • JDRF Heads, Virtually, to ADA’s 80th Scientific Sessions

    May 26, 2020

    The American Diabetes Association’s (ADA) 80th Scientific Sessions is almost here! From June 12-16, scientists and healthcare professionals will gather, virtually, at...

  • Advancing Cures with Type 1 Diabetes Clinical Trials

    May 20, 2020

    JDRF funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people with this disease....

  • Meet the Scientist: Local Immune Suppression with a Novel Protein

    May 13, 2020

    Mark Poznansky, M.D., Ph.D., wants the seemingly impossible—a person with type 1 diabetes (T1D) has a procedure where beta cells are placed...

  • Insulin Contains the Expected Quantity of Active Insulin

    May 11, 2020

    Credit: Diabetes Care In December 2017, the type 1 diabetes (T1D) community got a jolt, when a publication, testing the insulin concentrations...

  • A Promising (Preclinical) Vaccine for Type 1 Diabetes

    May 7, 2020

    Wouldn’t it be nice if you could take a vaccine in infancy, and type 1 diabetes would not develop? Preclinical research suggests it might not be that far away.

  • Dr. Carla Greenbaum Talks about T1D TrialNet During the COVID-19 Pandemic

    May 7, 2020

    Carla Greenbaum, M.D., chair of TrialNet—an international JDRF-supported network that is dedicated to finding cures for type 1 diabetes (T1D)—and a professor...